PolyPid Ltd
NASDAQ:PYPD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
PolyPid Ltd
EPS (Diluted)
PolyPid Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PolyPid Ltd
NASDAQ:PYPD
|
EPS (Diluted)
-$2
|
CAGR 3-Years
67%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
EPS (Diluted)
$1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-4%
|
|
|
Sol Gel Technologies Ltd
NASDAQ:SLGL
|
EPS (Diluted)
-$3
|
CAGR 3-Years
N/A
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Mediwound Ltd
NASDAQ:MDWD
|
EPS (Diluted)
-$2
|
CAGR 3-Years
19%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
S
|
Seach Medical Group Ltd
TASE:SEMG
|
EPS (Diluted)
₪0
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
EPS (Diluted)
-₪1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
PolyPid Ltd
Glance View
PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
See Also
What is PolyPid Ltd's EPS (Diluted)?
EPS (Diluted)
-2.1
USD
Based on the financial report for Dec 31, 2025, PolyPid Ltd's EPS (Diluted) amounts to -2.1 USD.
What is PolyPid Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
49%
Over the last year, the EPS (Diluted) growth was 57%. The average annual EPS (Diluted) growth rates for PolyPid Ltd have been 67% over the past three years , 49% over the past five years .
